Coronavirus Disease 2019 (COVID-19)
Coronavirus disease (COVID-19) is a new strain that was discovered in 2019 and has not been previously identified in humans.
Common signs of infection include respiratory symptoms, fever, cough, shortness of breath and breathing difficulties. In more severe cases, the infection can cause pneumonia, severe acute respiratory syndrome, kidney failure and even death.
Standard recommendations to prevent infection spread include regular hand washing, covering mouth and nose when coughing and sneezing. Avoid close contact with anyone showing symptoms of respiratory illness such as coughing and sneezing.
Clinical Videos for Healthcare Providers
The first version on this living guidance focuses on corticosteroids. It contains a strong recommendation for systemic corticosteroids in patients with severe and critical covid-19, and a weak or conditional recommendation against systemic corticosteroids in patients with non-severe covid-19.
Patients who are assessed by a Health Care Worker and meet all the criteria below will be considered for home-based isolation and care; laboratory-confirmed COVID-19, asymptomatic patients or patients with mild symptoms of COVID-19, absence of comorbidities, and access to a suitable space for home-based isolation and care.
As the COVID‐19 pandemic continues to unfold here in Kenya, more and more patients are requiring oxygen. To increase the capacity of healthcare facilities to provide oxygen to more patients, we have installed Oxygen Gas Manifolds in the emergency departments at the county referral hospitals in Machakos, Kiambu (COVID-19 isolation centre) and Kajiado counties and at the Alupe Sub-County Hospital COVID-19 isolation centre in Busia county. These are the hardest hit counties at the moment and we continue to seek additional support to support more facilities.
The findings of this well done randomized controlled trial indicate that in patients with COVID-19 pneumonia, that dexamethasone improves 28d mortality compared to placebo in patients requiring invasive mechanical ventilation (IMV) (NNT = 8.5) and those patients requiring oxygen therapy (NNT = 29).
This document provides general guidance for Emergency Medical Service (EMS) preparedness and response to COVID19. At a local and state level, regulations and resource configurations may vary. In addition to these recommendations, EMS agencies should consult with local stakeholders.
You are a health care provider in a developed country. Several patients await your care. These patients are suspected of having COVID-19 and have been triaged by severity of illness. We recommend starting with the mildly ill patient, but you are free to see them in any order.